Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Braves Recall Touki Toussaint, Option Kyle Wright

By | at

Per a team release, the Braves have recalled top prospect Touki Toussaint from Triple-A Gwinnett and optioned another, righty Kyle Wright, to the minors.

Toussaint, the 16th overall pick in the 2014 draft, was acquired from Arizona in a curious 2015 salary dump that also sent righty Bronson Arroyo to Atlanta. The 22-year-old broke out in a big way last season, striking out over 10 men per nine at both AA-Mississippi and AAA-Gwinnett en route to a late-season, five-start cameo in the bigs. Command has long been the question for the flamethrowing Toussaint, whose stuff – a double-plus fastball and knee-buckling curve – is said to be some of the minors’ best. Per David O’Brien of the Athletic, Toussaint will begin his 2019 MLB work out of the Braves’ bullpen.

Wright, a 23-year-old righty selected 5th overall in the 2017 draft, and even more highly-regarded than Toussaint in most circles, has struggled mightily in his initial MLB taste. In three starts this season, the former Vanderbilt product walked (10) nearly as many as he struck out (11), and allowed a staggering four homers in just 14 innings pitched. Last season’s cameo wasn’t much better, so it may indeed be time for the 6’4 righty to simmer longer below. Wright tore through the Atlanta system in just a year and a half, but has yet to post the dominant strikeout rates the club surely hoped to see against lesser competition.

Tigers Outright Mikie Mahtook To Triple-A

By | at

TODAY: Mahtook cleared waivers and has been outrighted to Triple-A, the Tigers announced.

THURSDAY: The Tigers announced this morning that they’ve designated outfielder Mikie Mahtook for assignment. His spot on the 25-man roster will go to fellow outfielder JaCoby Jones, who has been reinstated after opening the season on the injured list due to a shoulder sprain.

Mahtook, 29, had a promising first year with the Tigers in 2017 after being acquired in a minor trade with the Rays in the preceding offseason. The 2011 first-round pick slashed .276/.330/.457 with a dozen homers in 379 plate appearances and gave the organization some hope that he could be a useful pieces for years to come, given the amount of club control he had remaining.

Unfortunately, Mahtook’s production cratered in 2018 as his strikeout rate soared north of 26 percent while the .324 BABIP he turned in a year prior cratered to a career-low .238. Mahtook saw his hard-contact and line-drive rates both decline, while he hit infield pop-ups at a career-worst clip as well.

Things haven’t gone better for Mahtook in the early stages of the 2019 campaign, either. He’s hitless through 25 plate appearances, including 11 strikeouts, and a recent misplay in center field turned a routine Eric Stamets single into a little league homer.

Detroit will have a week to either trade Mahtook or run him through outright waivers, at which point he’d remain under organizational control should the team wish to assign him to a minor league affiliate. Mahtook has never been previously outrighted and doesn’t have the requisite three years of big league service to reject an outright assignment, so electing free agency wouldn’t be an option for him.

Mahtook’s DFA means that Jones can be penciled in for everyday at-bats in center field, while former Padres and Braves prospect Dustin Peterson, whom Detroit claimed off waivers last September, will stick on the big league roster as the primary reserve outfielder for the time being. That’ll leave Detroit without a true backup center fielder; Peterson and utilityman Niko Goodrum are the only players on the big league roster with experience at the position, though that pair has combined for just 331 innings of work at the position (nearly all in the minor leagues). It’s possible that another move is coming to add a more natural backup, but for now Jones, who hit .207/.266/.364 in 467 PAs last season, appears ticketed for a heavy workload.

Injury Notes: Miller, LeBlanc, Borucki, Blue Jays

By | at

The Nationals have placed right-hander Justin Miller on the 10-day IL due to a lower back strain.  Righty Austen Williams has been called up to take Miller’s spot on the 25-man roster.  Miller has a 5.68 ERA over 6 1/3 frames out of Washington’s bullpen this season, with all of that damage coming from runs allowed in each of his last three appearances.  Miller’s absence is yet another problem for the beleaguered Nats bullpen, which has a league-worst 8.12 cumulative ERA this season.  The Nationals were seemingly close to a deal with Bud Norris before that rumored contract fell through, so the team is actively looking for ways to upgrade its relief core.  There’s certainly opportunity here for a new face like Williams to make an impact, as the 26-year-old had an outstanding Spring Training and has turned in good results out of the bullpen at the minor league level since becoming a full-time reliever last season.  Williams made his MLB debut in 2018, tossing 9 2/3 innings over 10 games with the Nats.

Here’s some more injury news from around the league…

  • Wade LeBlanc left during the fifth inning of last night’s game due to right oblique strain, and the Mariners southpaw is likely headed to the injured list.  (MLB.com’s Greg Johns was among those with the details.)  Tommy Milone or possibly Justus Sheffield seem like the top candidates to replace LeBlanc in Seattle’s rotation, though nothing will be confirmed until LeBlanc undergoes an MRI today to access the damage.  The 34-year-old LeBlanc has been a solid arm for the M’s since rejoining the team on a minor league deal in March 2018, posting a 3.79 ERA while starting 30 of 35 games.  This success resulted in an option-heavy extension between LeBlanc and the Mariners last July.
  • Blue Jays righty Ryan Borucki’s bothersome elbow will be re-evaluated in two weeks after the hurler received a cortisone shot, Sportsnet.ca’s Shi Davidi writes.  Borucki first experienced the problem in the final week of Spring Training, and hasn’t thrown since a bullpen session on April 3.
  • In other Blue Jays injury news from Davidi’s piece, Ryan Tepera has begun a rehab assignment and could potentially join the team as early as this weekend, as the reliever tries to bounce back from his own elbow problems.  David Phelps is set to begin bullpen sessions next week as the reliever continues his recovery from Tommy John surgery, with an eye towards a midseason return.  Devon Travis is scheduled for baseball activities next week, though a 60-day IL placement in the wake of meniscus surgery means that Travis isn’t eligible to return to the Jays’ big league roster until late May.

Phillies Have Yet To Discuss Extensions With Realmuto, Hoskins

By | at

The Phillies haven’t yet broached the subject of a contract extension with either catcher J.T. Realmuto or first baseman Rhys Hoskins, the two players told reporters (including Philly.com’s Scott Lauber and Jim Salisbury of NBC Sports Philadelphia).  The duo each expressed interest in remaining with the Phillies over the long term, and neither seemed perturbed by a lack of negotiations.

Realmuto can become a free agent after the 2020 season, though despite mutual interest in an extension from both the catcher and the team, Lauber writes that “neither side feels urgency to rush into anything” since Realmuto only joined the Phillies in February.  It stands to reason that the Phils will wait until the winter to really delve into contract talks, though obviously another All-Star caliber season from Realmuto will only raise his asking price.  There’s even less of a rush to extend Hoskins, as the slugging first baseman is under team control through the 2023 season and isn’t even arbitration-eligible until the 2020-21 offseason.

Looming over this whole discussion, of course, is the state of free agency, as the last two offseasons of slowed activity have resulted in an incredible number of contract extensions signed over the last two months.  The Phillies themselves have already been a part of that action, inking Aaron Nola to a four-year extension worth $45MM in guaranteed money.  The extension flurry has seen both established stars (like Realmuto) and younger pre-arb players (like Hoskins) taking a payday now rather than test what has become an increasingly unfriendly free agent market to veteran players.

Realmuto will turn 30 in March 2021, while Hoskins will turn 31 prior to the 2024 season.  In Hoskins’ case, he stands to make some solid money during his arbitration years if he continues to hit, as the arb process rewards traditional counting stats like home runs and RBI.  A pricey multi-year deal, however, could be harder to come by unless the next collective bargaining agreement between MLB and the players’ union (the current deal expires in December 2021) changes the free agent climate.

“I think all of us players have noticed [what’s happened in free agency],” Hoskins said.  “Obviously we hope stuff like that flips by the time that we get there. I don’t know if it will ever get back to where it was, but hopefully it starts trending in the opposite direction of where it is right now. I think a lot of those questions are going to be answered after [2021].”

According to Salisbury, the Phillies previously tried to extend Hoskins prior to the 2017 season, before he had even made his Major League debut.  Philadelphia used a similar approach with another top prospect in Scott Kingery last year, signing Kingery to a six-year, $24MM deal that gave the Phils club options over three of Kingery’s free agent years.

Hoskins’ camp declined those earlier offers, though Hoskins has since changed representation to the Boras Corporation.  As much as Scott Boras is known for taking his clients into the open market, Hoskins reiterated that his agent is perfectly willing to negotiate extensions if they make sense for the player.  It should be noted that Boras has a number of noteworthy extensions on his record, including Xander Bogaerts’ new pact with the Red Sox from just a couple of weeks ago.

Yankees Activate C.C. Sabathia From Injured List

By | at

The Yankees have activated southpaw C.C. Sabathia from the injured list, as per a club press release.  Left-hander Stephen Tarpley was optioned to Triple-A last night to create a 25-man roster spot for Sabathia, who is set to start today’s game against the White Sox.

Sabathia underwent both a minor knee surgery and an angioplasty during the offseason, leading the Yankees to make the IL placement in order to give the 38-year-old time to properly ramp up his preparation.  He technically began the season on the active roster, in order to get a five-game suspension out of the way (Sabathia was issued the suspension for hitting Jesus Sucre with a pitch in a game late last year) before he hit the IL on April 3.

Now, Sabathia is ready to begin what will be his 19th and final Major League season.  The veteran re-signed with New York on a one-year, $8MM deal in early November, as there was never much doubt that Sabathia would don the pinstripes one more time.  Though the Yankees will monitor Sabathia’s innings and usage as a nod to his age and injury history, he has continued to provide solid results in the rotation.  Sabathia has a 3.76 ERA, 7.7 K/9 rate, and 2.48 K/BB rate over 481 1/3 innings since the start of the 2016 season.

Sabathia’s return patches at least one hole in the Yankees’ injury-riddled roster, though the team still has a whopping 11 players on the injured list.  Rotation-wise, Sabathia joins Masahiro Tanaka, James Paxton, J.A. Happ in the starting five, while Domingo German continues to fill in for the sidelined Luis Severino.

Dellin Betances Diagnosed With Bone Spur In Shoulder

By | at

Yankees reliever Dellin Betances is dealing with a bone spur in his right shoulder, GM Brian Cashman announced tonight to reporters including Kristie Ackert of the New York Daily News (via Twitter). He’ll need further treatment and rest, pushing back his anticipated timeline to return to the active roster.

The best guess at present is that Betances will need at least three weeks of rest. If things go well from that point, he could be ready for the big leagues in approximately six or seven weeks. While the news isn’t as bad as it could’ve been, the Yanks were surely hoping that Betances would be nearing a return at this point rather than re-starting the process.

While the Yanks can’t hope for Betances to re-join the pen until June, they’ll still have ample time to evaluate their roster needs in advance of the trade deadline. In the meantime, they’ll simply have to go without a pitcher who has been among the game’s most consistently dominant relievers for some time now. Fortunately, this ballclub carries a stacked relief unit with or without Betances.

Thus far, the Yankees’ season has been marred completely by a barrage of injuries. It’s not particularly surprising to see a few hurlers dealing with issues, and nobody is shocked to find Troy Tulowitzki and Jacoby Ellsbury on the shelf. But the Yankees’ injured list now borders on the absurd, with a run of incredibly talented players on the shelf — many with uncertain timelines for a return.

It’s never good to see players out of action, but the situation creates an undeniably fascinating dynamic. With the Red Sox limping out of the gates and the Rays starting hot, it now seems to be a true three-way race — with all the competitors also readying to jockey for position against other possible Wild Card clubs. We’re barely two weeks into the season, but the American League already looks quite a bit less top heavy than it appeared on paper.

Health Notes: Trout, Jeffress, Murphy, Tuivailala, Volquez

By | at

It doesn’t seem as if the Angels will end up needing to place superstar Mike Trout on the injured list. The club indicated in an announcement today that he’s recovering well after tweaking his groin muscle recently, with an MRI showing that the swelling is subsiding and Trout “report[ing] daily improvement.” Another medical review is scheduled for Sunday. It’s not known whether Trout could be activated thereafter, but a decision will need to be made sooner than later. While the club obviously prefers not to go without him any longer than necessary, the worst outcome would be for Trout to make things worse by rushing back.

More on the injury front from around the game:

  • Late-inning man Jeremy Jeffress is expected to return to the Brewers after one more rehab outing, skipper Craig Counsell tells reporters including Tom Haudricourt of the Milwaukee Journal-Sentinel (Twitter link). Jeffress has been moving at about the pace that was hoped when it was announced he’d open the year on the injured list with a somewhat balky shoulder. He has been knocked around a bit on his rehab assignment, though that’s hardly the focus. Jeffress says he’s gaining velocity and feeling stronger as he goes. He’ll soon get the chance to try to replicate his magnificent 2018 season.
  • Rockies first baseman Daniel Murphy will not require surgery to repair his fractured left index finger, Patrick Saunders of the Denver Post reports on Twitter. That seems generally promising, if only because it’s always preferable to avoid the risks of a procedure. It’s not clear exactly how long he’ll be sidelined; at last look, the club expected he’d be out of commission through at least the end of the month, but that seems like the bare minimum. Whatever the duration, it’ll be more than desirable for a team that currently sports the league’s worst offense.
  • While there’s still no precise timeline, a return to action is now in sight for Mariners reliever Sam Tuivailala. He’s still at least a month away from the majors but is nearing live BP sessions, MLB.com’s Greg Johns reports via Twitter. The 26-year-old hurler, who is working back from a torn Achilles, appears to be a bit ahead of schedule as compared to expectations last fall. He still has a fair number of additional hurdles yet to clear, of course, but it’s generally promising for the increasingly interesting M’s.
  • The Rangers still lack clarity regarding the severity of the elbow injury to veteran starter Edinson Volquez. For now, the plan is to put him on the shelf for the next four to six weeks before bringing him in for imaging and a medical review, Jeff Wilson of the Fort Worth Star-Telegram was among those to cover (Twitter link). It’s a bit of an unusual situation, but it seems the hurler preferred to wait; the team agreed since he’d be sidelined regardless and the results would be more reliable after swelling has gone down. Volquez has suggested he’ll retire if he has again blown out his ulnar collateral ligament. If that’s not necessary, he could presumably return to pitch this year in Texas. It seems we’ll all wait a while longer to learn the outcome.

Previewing 2019-20’s Opt-Out Clause Decisions

By | at

Some few contracts include provisions giving the player control over one or more seasons by affording the chance to opt out of the remainder of the deal. Take the bird in hand or see how many you can net from the free-agent bush? Market changes have impacted the math for some players, but the open market still has riches to offer. We don’t know how things will look for any given player at season’s end, but here’s how it’s shaping up at the outset of the 2019 campaign:

Elvis Andrus, SS, Rangers: Three years, $43MM: The 2016-17 version of Andrus — and the one we saw through the season’s first two weeks in 2018 — looked every bit like a player who would exercise the first of two opt-out clauses in his contract (which came at the end of the 2018 season). From Opening Day 2016 through April 11 last year, Andrus posted a terrific .301/.352/.459 batting line with 30 homers, 78 doubles, 11 triples and 49 steals through 1318 plate appearances. Paired with his glovework at shortstop, he looked very capable of topping the remaining four years and $58MM on his contract. Unfortunately, he suffered an elbow fracture, missed two months, and returned to hit only .245/.289/.347 in his final 367 plate appearances. An offseason of rest looks to have done him some good, as he’s hitting .380/.392/.500 through 51 PAs. Unlike several players on this list, there’s an actual chance that Andrus could test the open market, though free agency hasn’t been kind to players on the wrong side of 30 in recent years.

Jake Arrieta, RHP, Phillies: One year, $20MM (unless Phillies exercise two-year, $40MM option for 2021-22): Arrieta’s first season with the Phils was solid, if unremarkable. He tallied 172 2/3 innings and gave the team a 3.96 ERA with fielding-independent metrics that didn’t stray too far from that ERA (4.26 FIP, 4.08 xFIP, 4.29 SIERA). The former Cy Young winner’s velocity is down a couple miles per hour from its peak levels, and while Arrieta showed good control and ground-ball tendencies in 2018, he no longer appears to be a strikeout pitcher. Given that he’ll pitch next season at age 34, it doesn’t seem all that likely that the Phillies will sign up to tack on another pair of $20MM seasons. With a strong 2019 effort, it’s possible that Arrieta positions himself to land a two-year deal with a larger guarantee but lower annual rate (e.g. two years, $30MM), so it’s not out of the question that he’d opt out at season’s end, even if seems unlikely at present.

Yu Darvish, RHP, Cubs: Four years, $81MM: Darvish’s first season in Chicago was an unmitigated disaster, as a series of arm injuries limited him to just 40 innings of work. His velocity isn’t where it was in previous seasons, and in this season’s small sample of three starts, he’s walked more batters than he’s punched out. It’s hard to envision any scenario in which Darvish opts out of his contract; even if he stormed back to ace status and won an NL Cy Young Award, I’m not sure he’d top $81MM as a 33-year-old free agent with a qualifying offer hanging over his head. The Cubs appear stuck with the contract and will need to simply hope for a rebound.

Jason Heyward, OF, Cubs: Four years, $86MM (assuming he makes 550 PAs): Heyward has had a scalding hot start to the season, mashing at a .351/.444/.676 pace. Through 45 plate appearances, he’s already halfway to his home run total from a 2018 season in which he came to he plate 489 times. Even if Heyward’s bat proves to be rejuvenated to its 2015 levels, however, it’s virtually unfathomable that he’d walk away from the remaining $86MM on this contract. His poor results in his first three seasons with the Cubs still loom large enough that a monster year at the dish would be met with a heavy dose of skepticism, and he’ll turn 30 in August.

Kenley Jansen, RHP, Dodgers: Two years, $38MM: After seven seasons as a near-unstoppable force in the Dodgers’ bullpen, Jansen looked mortal in 2018 when he logged a 3.01 ERA (his first time ever topping 3.00) and 10.3 K/9 (his first time south of 13.0). A strong enough rebound campaign could embolden Jansen to seek out a three-year deal at a lower annual salary than the $19MM remaining on his contract; the Rockies gave Wade Davis a total of $52MM for the same three-year age span that Jansen will be entering (32-34). He’s already rejected one qualifying offer in his career, so he wouldn’t be eligible to receive a second one (even though he landed with the same team that winter).

J.D. Martinez, DH/OF, Red Sox: Three years, $62.5MM: The general expectation in the 2017-18 offseason was that Martinez’s 2017 season (.303/.376/.690, 45 home runs) would be a peak year. Instead, he turned in an arguably even more productive 2018 season with the Red Sox, hitting a ridiculous .330/.402/.629 with 43 home runs in 649 PAs — the second-highest total of his career. Martinez is off to another strong start in 2019, and despite a frosty climate for free agents, one can only wonder if he’d be tempted to once again test free agency if he can post a third consecutive season of 40-plus homers with an OPS north of 1.000. One wrinkle to consider is that barring an unexpected midseason trade, Martinez would have a qualifying offer attached to him this time around; that wasn’t true of his last trip through free agency, as he’d been traded from Detroit to Arizona midseason.

Stephen Strasburg, RHP, Nationals: Four years, $100MM: Strasburg is still a strikeout machine who posts big totals in swinging-strike and opponents’ chase rates, but his 93.1 mph average fastball in 2019 is well south of last year’s 94.5 mph (to say nothing of his career 95.3). The former No. 1 pick was a big part of the Nats’ rotation in 2018 and should be again this year, but he was more good than great last year (130 innings, 3.74 ERA, 10.8 K/9, 2.6 BB/9, 43.6 GB%). Moreover, Darvish and a much younger Patrick Corbin are the only two pitchers who have topped $100MM in guarantees over the past two offseasons. Strasburg would be hit with a qualifying offer if he opted out, and he’d be betting against recent trends as a 31-year-old pitcher looking to cash in on a nine-figure contract. He can ask Dallas Keuchel how well that strategy works.

Details On Tony Watson’s Contract

By | at

Giants reliever Tony Watson triggered many of the available escalators in his contract last year, MLBTR’s Steve Adams reports (Twitter link), allowing him to add $3MM in earnings to what had been a $3.5MM guaranteed salary for the 2019 season. In addition to his now-$6.5MM salary this year, the southpaw can also trigger quite a few incentives by continuing to rack up appearances.

Watson and his reps were forced to get creative when his market didn’t quite develop as hoped last winter. He ended up joining the San Francisco organization in late February. The contract softened the luxury-tax hit for the club with a lower-than-anticipated annual guarantee, but also came with upside for the player.

The deal promised Watson $9MM, a figure that covered two full seasons as well as a $2.5MM player option for the 2020 campaign. That option still protects his downside in the event of an injury or performance slide. Watson will surely hope his market value well outstrips it come this fall; in that case, he’ll instead take a $500K buyout.

On the incentive side, the contract was known to have included $2.5MM in games-finished bonuses. That was never particularly likely to come into play and indeed has not. As Adams explains, though, it also included provisions allowing for substantial earnings for being called upon to pitch.

Watson’s 66-frame 2018 showing allowed him to boost his 2019 salary to $6.5MM. He can add to that with incentive pay this year: $500K apiece upon reaching his 25th, 30th, 35th, 40th, 45th, and 50th games pitched. He’ll earn another $1MM if he can reach 55 games. There are similar numbers available for 2020, though it seems unlikely they’ll be brought into play.

Add it all up, and Watson’s 2019 incentive package maxes out at $4MM — meaning he could end the present season with $10.5MM in total compensation. And it’s all quite achievable so long as he stays healthy.

These contract details are obviously relevant for player and team, but they’re also notable from the perspective of potential trade suitors. There’ll be a fair bit of salary to account for if Watson is dealt this summer. It’s certainly not hard to imagine a scenario where Watson does indeed end up on the block this July. He’s a 2.66 ERA hurler through 523 2/3 MLB innings and hasn’t finished a complete season with an ERA north of 3.38 with the exception of his debut campaign.

Last year, Watson rung up more than a batter per inning via strikeout while walking less than two per nine. That enabled him to carry a shiny 2.59 ERA over 66 frames and represented a reversal of some worrying peripheral trends from the prior two seasons. In the early going in 2019, the 33-year-old has shown a velocity decline (over two ticks below his career average) and managed only a single strikeout in 4 2/3 outings. But he’s also generating swinging strikes at a whopping 19.3% rate. He also hasn’t handed out a walk and has permitted just one earned run.

Dellin Betances Slated To Receive MRI

By | at

Rehabbing Yankees reliever Dellin Betances is not progressing on quite the timeline that might have been hoped. Manager Aaron Boone said today that a recent simulated game “didn’t go great,” as MLB.com’s Bryan Hoch was among those to tweet. Betances is now heading back to New York to undergo an MRI on his shoulder.

Previously diagnosed with an impingement after experiencing a worrying spring velocity drop, Betances had been hoping to rest a bit and then ramp right back up. It seems now that the down time did not fully resolve the issues in the joint, which makes for no shortage of uncertainty for both player and team.

The Yankees have plenty of options to fill in for Betances and the resources to add more relievers if need be. But the club is already dealing with multiple injuries in other areas of the roster. At this stage of the season, at least, it can’t hope to find a reliever of Betances’s quality for anything approaching a reasonable price.

Things are even more concerning for Betances himself, as the big righty is playing out his final season of arbitration eligibility. High velocity and durability have been among his two biggest calling cards over a thus-far stellar career. Now, the 31-year-old will need to get healthy and regain the arm speed that has allowed him to post a 2.36 ERA with 14.6 K/9 over 381 total MLB innings.. If and when he manages that, there’ll still be some newfound uncertainty surrounding his health outlook.

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top